Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-09-04FDA Approved: REGLAN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for REGLAN (metoclopramide hydrochloride), enabling changes under a supplemen…
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Postoperative Nausea and Vomiting and Acupuncture/Acupressure [Phase 2, Phase 3]
Phase 2/3 clinical trial assessing acupuncture/acupressure for postoperative nausea and vomiting has completed.
-
FDA approval · 2009-07-21FDA Approved: EMEND — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for EMEND (aprepitant) from Merck Sharp & Dohme LLC.
-
FDA approval · 2009-06-30FDA Approved: REGLAN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Reglan (metoclopramide hydrochloride) submitted by ANI Pharmaceuticals, Inc. for NDA 017854.
-
FDA approval · 2009-06-30FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for metoclopramide.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-06-16Clinical Trial Update: Atropine to Prevent Nausea and Vomiting After Spinal Anesthesia for Caesarean Section [Phase 4]
Phase 4 trial evaluating atropine to prevent postoperative nausea and vomiting after spinal anesthesia in cesarean sections has completed.
-
CLINICAL_TRIALS trial_result · 2009-05-05Clinical Trial Update: Efficacy of Prevention for Postoperative Nausea and Vomiting After Intrathecal Morphine in Cesarean Section [NA]
This clinical trial update reports on the efficacy of prevention strategies for postoperative nausea and vomiting after intrathecal morphine…
-
CLINICAL_TRIALS research · 2009-02-04Clinical Trial Update: Oral Aprepitant and Lower Dose Dexamethasone Versus Aprepitant Alone for Preventing Postoperative Nausea and Vomiting (PONV) After Elective Laparoscopic Surgeries [NA]
This clinical trial update compares regimens of aprepitant with and without lower-dose dexamethasone to prevent postoperative nausea and vom…
-
CLINICAL_TRIALS trial_result · 2009-01-16Clinical Trial Update: Implementation Study of the PostOperative Nausea and Vomiting Prediction Rule [NA]
This completed clinical trial assessed the implementation of a postoperative nausea and vomiting (PONV) prediction rule in clinical practice…
-
FDA approval · 2008-12-18FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application for prochlorperazine maleate from Jubilant Cadista Pharmaceuticals Inc., updating the labeling for t…
-
FDA approval · 2008-10-28FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for metoclopramide from ANI Pharmaceuticals, Inc., for an already approved generic product. This…
-
FDA approval · 2008-10-23FDA Approved: ONDANSETRON — Supplemental Application (AvKARE)
FDA approved a supplemental application for Ondansetron from AvKARE under ANDA078152, authorizing the generic product's marketing.
-
FDA approval · 2008-09-08FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Prochlorperazine Maleate from Chartwell RX, LLC, indicating an approved change under an existing…
-
FDA approval · 2008-08-18FDA Approved: ONDANSETRON — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for ondansetron from Glenmark Pharmaceuticals Inc., USA, for a generic product; this action may invo…
-
FDA approval · 2008-08-18FDA Approved: ONDANSETRON — Supplemental Application (AvKARE)
FDA approved a supplemental application for AvKARE's ondansetron (ANDA 078152), resulting in labeling updates for the product. The action co…
-
FDA approval · 2008-06-30FDA Approved: GRANISETRON — Original Application (Fresenius Kabi USA, LLC)
FDA approved an original application for granisetron hydrochloride (granisetron) by Fresenius Kabi USA, LLC, a generic antiemetic.
-
FDA approval · 2008-06-12FDA Approved: METOCLOPRAMIDE — Original Application (Ipca Laboratories Limited)
FDA approved the original generic application for metoclopramide by Ipca Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2008-05-28Clinical Trial Update: Prevention of Postoperative Nausea and Vomiting (PONV) by Acupressure [Phase 4]
A Phase 4 clinical trial evaluated whether acupressure at the P6 point can prevent postoperative nausea and vomiting.
-
FDA approval · 2008-04-23FDA Approved: ONDANSETRON HYDROCHLORIDE — Original Application (Onesource Specialty Pharma Limited)
FDA approved the original application for ondansetron hydrochloride (generic) from Onesource Specialty Pharma Limited.
-
FDA approval · 2008-04-23FDA Approved: ONDANSETRON HYDROCHLORIDE — Original Application (Onesource Specialty Pharma Limited)
FDA approved ondansetron hydrochloride under an Original Application (ANDA078257) for use as an antiemetic. The generic product is developed…
-
FDA approval · 2008-02-29FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Cipla USA Inc.)
FDA granted supplemental approval for palonosetron hydrochloride from Cipla USA Inc. under NDA 021372.
-
FDA approval · 2008-02-13FDA Approved: GRANISETRON HYDROCHLORIDE — Original Application (Bionpharma Inc.)
FDA approved the original application for granisetron hydrochloride by Bionpharma Inc., enabling the generic product. Granisetron hydrochlor…
-
FDA approval · 2008-01-04FDA Approved: ONDANSETRON — Supplemental Application (Chartwell RX, LLC)
FDA granted a supplemental approval for ondansetron (Chartwell RX, LLC) under an ANDA.
-
FDA approval · 2007-12-21FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for Metoclopramide Hydrochloride (generic) from Chartwell Governmental & Specialty RX, LLC. The acti…
-
FDA approval · 2007-11-30FDA Approved: ONDANSETRON — Original Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approval notice for a generic ondansetron hydrochloride product (ondansetron) by Taro Pharmaceuticals U.S.A., Inc. under an original AND…